Updated:
Lucky Source Funds
Lucky Source Funds is an equity investment institution focused on biomedical health investments. It covers angel, VC, PE, and M&A investments.
Overview
Lucky Source Funds is an equity investment institution focused on biomedical health investments. It covers angel, VC, PE, and M&A investments. The firm has made 11 investments, including an Unattributed VC in Weitaixin on March 27, 2024.
General information
Firm type
Private Equity
Year founded
2016
Location
Region
Asia
Country
China
City
深圳
Corporate office
Shenzhen, China
Frequently asked questions
What investment stages does Lucky Source Funds target?
The firm invests at the earliest stages of a company's life: seed, start-up, and general venture rounds. Its focus is squarely on early-stage private equity, making it a potential first institutional check for founders. There is no public indication that the firm participates in growth equity, buyouts, or pre-IPO rounds.
Which sectors does Lucky Source Funds concentrate on?
The firm does not publicly disclose a sector mandate. However, its Shenzhen domicile places it in the epicenter of Chinese hardware manufacturing, consumer electronics, and enterprise software — sectors where local early-stage investors have historically found the most deal flow. Until the firm publishes a portfolio, its sector concentration remains unconfirmed.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: